Literature DB >> 25625254

Laparoscopic surgery and muscle relaxants: is deep block helpful?

Aaron F Kopman1, Mohamed Naguib.   

Abstract

It has been hypothesized that providing deep neuromuscular block (a posttetanic count of 1 or more, but a train-of-four [TOF] count of zero) when compared with moderate block (TOF counts of 1-3) for laparoscopic surgery would allow for the use of lower inflation pressures while optimizing surgical space and enhancing patient safety. We conducted a literature search on 6 different medical databases using 3 search strategies in each database in an attempt to find data substantiating this proposition. In addition, we studied the reference lists of the articles retrieved in the search and of other relevant articles known to the authors. There is some evidence that maintaining low inflation pressures during intra-abdominal laparoscopic surgery may reduce postoperative pain. Unfortunately most of the studies that come to these conclusions give few if any details as to the anesthetic protocol or the management of neuromuscular block. Performing laparoscopic surgery under low versus standard pressure pneumoperitoneum is associated with no difference in outcome with respect to surgical morbidity, conversion to open cholecystectomy, hemodynamic effects, length of hospital stay, or patient satisfaction. There is a limit to what deep neuromuscular block can achieve. Attempts to perform laparoscopic cholecystectomy at an inflation pressure of 8 mm Hg are associated with a 40% failure rate even at posttetanic counts of 1 or less. Well-designed studies that ask the question "is deep block superior to moderate block vis-à-vis surgical operating conditions" are essentially nonexistent. Without exception, all the peer-reviewed studies we uncovered which state that they investigated this issue have such serious flaws in their protocols that the authors' conclusions are suspect. However, there is evidence that abdominal compliance was not increased by a significant amount when deep block was established when compared with moderate neuromuscular block. Maintenance of deep block for the duration of the pneumoperitoneum presents a problem for clinicians who do not have access to sugammadex. Reversal of block with neostigmine at a time when no response to TOF stimulation can be elicited is slow and incomplete and increases the potential for postoperative residual neuromuscular block. The obligatory addition of sugammadex to any anesthetic protocol based on the continuous maintenance of deep block is not without associated caveats. First, monitoring of neuromuscular function is still essential and second, antagonism of deep block necessitates doses of sugammadex of ≥4.0 mg/kg. Thus, maintenance of deep block has substantial economic repercussions. There are little objective data to support the proposition that deep neuromuscular block (when compared with less intense block; TOF counts of 1-3) contributes to better patient outcome or improves surgical operating conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25625254     DOI: 10.1213/ANE.0000000000000471

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  26 in total

1.  A multifaceted individualized pneumoperitoneum strategy for laparoscopic colorectal surgery: a multicenter observational feasibility study.

Authors:  Oscar Diaz-Cambronero; Blas Flor Lorente; Guido Mazzinari; Maria Vila Montañes; Nuria García Gregorio; Daniel Robles Hernandez; Luis Enrique Olmedilla Arnal; Maria Pilar Argente Navarro; Marcus J Schultz; Carlos L Errando
Journal:  Surg Endosc       Date:  2018-06-27       Impact factor: 4.584

Review 2.  [Deep neuromuscular blockade : Benefits and risks].

Authors:  C Unterbuchner; M Blobner
Journal:  Anaesthesist       Date:  2018-03       Impact factor: 1.041

3.  Is Deep Neuromuscular Relaxation Beneficial in Laparoscopic, Abdominal Surgery?

Authors:  Christoph Unterbuchner
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

4.  Does Deep Neuromuscular Block Facilitate Laparoscopic Surgery? The Picture is Not Clear.

Authors:  Béla Fülesdi; László Asztalos; Edömér Tassonyi
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

5.  Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial.

Authors:  Youn Joung Cho; Hyesun Paik; Seung-Yong Jeong; Ji Won Park; Woo Young Jo; Yunseok Jeon; Kook Hyun Lee; Jeong-Hwa Seo
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

Review 6.  Pediatric anesthesia for minimally invasive surgery in pediatric urology.

Authors:  Gianmario Spinelli; Maria Vargas; Gianfranco Aprea; Giuseppe Cortese; Giuseppe Servillo
Journal:  Transl Pediatr       Date:  2016-10

Review 7.  Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice.

Authors:  A Feldheiser; O Aziz; G Baldini; B P B W Cox; K C H Fearon; L S Feldman; T J Gan; R H Kennedy; O Ljungqvist; D N Lobo; T Miller; F F Radtke; T Ruiz Garces; T Schricker; M J Scott; J K Thacker; L M Ytrebø; F Carli
Journal:  Acta Anaesthesiol Scand       Date:  2015-10-30       Impact factor: 2.105

8.  Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial.

Authors:  Bart Torensma; Chris H Martini; Martijn Boon; Erik Olofsen; Bas In 't Veld; Ronald S L Liem; Mireille T T Knook; Dingeman J Swank; Albert Dahan
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 9.  What is the proper ventilation strategy during laparoscopic surgery?

Authors:  Youn Yi Jo; Hyun-Jeong Kwak
Journal:  Korean J Anesthesiol       Date:  2017-11-14

Review 10.  Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade.

Authors:  Stephan R Thilen; Sanjay M Bhananker
Journal:  Curr Anesthesiol Rep       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.